Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 12:01 ET | Source: Research and Markets

Europe Liver Disease Therapeutic Market and Value Chain Analysis 2025-2033 - Aging Populations, NAFLD Growth and Pharma Innovation Accelerate Treatment Adoption

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Europe Liver Disease Therapeutic Market Forecast 2025" has been added to ResearchAndMarkets.com's offering. The Europe Liver Disease Therapeutic...
March 14, 2025 07:17 ET | Source: Research and Markets

Liver Disease Therapeutic Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffmann-La Roche, Merck, Novartis, Sanofi, Pfizer, and Takeda

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Therapeutic Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
August 20, 2024 11:20 ET | Source: Research and Markets

Liver Disease Therapeutic Market Report 2024-2032 by Therapy Type Disease Type End Users Regions and Company Analysis

Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Liver Disease Therapeutic Market Report by Therapy Type Disease Type End Users Regions and Company Analysis 2024-2032" report has been added to ...
May 22, 2024 09:17 ET | Source: Research and Markets

Chronic Liver Disease Pipeline Insights Report, 2024: Development Stages, Key Players, Drug Mechanisms, Strategic Collaborations, and More

Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Chronic Liver Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive...
May 15, 2020 09:22 ET | Source: CMI

Liver Diseases Therapeutics Market to surpass US$ 24921.3 Million globally by end of 2027 - Coherent Market Insights

SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) -- Anti-rejection drugs/immunosupressants, anti-viral drugs, immunoglobulins, chemotherapy drugs, targeted therapies, vaccines are used in the treatment of...
March 03, 2016 05:30 ET | Source: Grand View Research

Liver Diseases Therapeutics Market Growth To Be Driven By Extensive R&D Practices By Industry Players Till 2022: Grand View Research, Inc.

San Francisco, March 03, 2016 (GLOBE NEWSWIRE) -- The liver diseases therapeutics market had value over USD 7,498.0 million in 2014. The major driving factors are increasing numbers of liver...